- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 9 residues within 4Å:- Chain A: N.328, E.331, E.332, L.335, K.344
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.1, NAG-NAG-BMA-MAN-MAN-MAN.1, NAG-NAG-BMA-MAN-MAN-MAN.1, NAG-NAG-BMA-MAN-MAN-MAN.1
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 10 residues within 4Å:- Chain A: N.10, E.11, S.12, F.13, M.26
- Chain B: G.11, G.12, V.13, A.14, G.15
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 13 residues within 4Å:- Chain B: Q.47, L.48, D.51, N.99, N.103
- Chain E: S.17, G.18, F.19, N.22, Q.422, G.424, T.425
- Chain F: S.94
5 PLIP interactions:4 interactions with chain E, 1 interactions with chain B- Hydrogen bonds: E:S.17, E:S.17, E:N.22, E:Q.422, B:D.51
NAG-NAG.8: 9 residues within 4Å:- Chain C: N.328, E.331, E.332, L.335, K.344
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.7, NAG-NAG-BMA-MAN-MAN-MAN.7, NAG-NAG-BMA-MAN-MAN-MAN.7, NAG-NAG-BMA-MAN-MAN-MAN.7
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 10 residues within 4Å:- Chain C: N.10, E.11, S.12, F.13, M.26
- Chain D: G.11, G.12, V.13, A.14, G.15
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 13 residues within 4Å:- Chain A: S.17, G.18, F.19, N.22, Q.422, G.424, T.425
- Chain B: S.94
- Chain D: Q.47, L.48, D.51, N.99, N.103
5 PLIP interactions:1 interactions with chain D, 4 interactions with chain A- Hydrogen bonds: D:D.51, A:S.17, A:S.17, A:N.22, A:Q.422
NAG-NAG.14: 9 residues within 4Å:- Chain E: N.328, E.331, E.332, L.335, K.344
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.13, NAG-NAG-BMA-MAN-MAN-MAN.13, NAG-NAG-BMA-MAN-MAN-MAN.13, NAG-NAG-BMA-MAN-MAN-MAN.13
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 10 residues within 4Å:- Chain E: N.10, E.11, S.12, F.13, M.26
- Chain F: G.11, G.12, V.13, A.14, G.15
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 13 residues within 4Å:- Chain C: S.17, G.18, F.19, N.22, Q.422, G.424, T.425
- Chain D: S.94
- Chain F: Q.47, L.48, D.51, N.99, N.103
5 PLIP interactions:4 interactions with chain C, 1 interactions with chain F- Hydrogen bonds: C:S.17, C:S.17, C:N.22, C:Q.422, F:D.51
- 3 x Z3Q- GAL- 5N6: 9-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid-(2-3)-beta-D-galactopyranose-(1-3)-2-azidoethyl 2-acetamido-2-deoxy-beta-D-glucopyranoside
Z3Q-GAL-5N6.4: 13 residues within 4Å:- Chain A: F.125, G.168, T.169, A.170, S.171, W.183, A.185, F.227, Y.229, F.238, V.273, R.294, F.295
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:A.185, A:F.227, A:F.295, A:F.295
- Hydrogen bonds: A:T.169, A:T.169, A:S.171, A:Y.229, A:R.294
- Water bridges: A:T.169
Z3Q-GAL-5N6.10: 13 residues within 4Å:- Chain C: F.125, G.168, T.169, A.170, S.171, W.183, A.185, F.227, Y.229, F.238, V.273, R.294, F.295
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:A.185, C:F.227, C:F.295, C:F.295
- Hydrogen bonds: C:T.169, C:T.169, C:S.171, C:R.294
- Water bridges: C:T.169
Z3Q-GAL-5N6.16: 13 residues within 4Å:- Chain E: F.125, G.168, T.169, A.170, S.171, W.183, A.185, F.227, Y.229, F.238, V.273, R.294, F.295
9 PLIP interactions:9 interactions with chain E- Hydrophobic interactions: E:A.185, E:F.227, E:F.295, E:F.295
- Hydrogen bonds: E:T.169, E:T.169, E:S.171, E:R.294
- Water bridges: E:T.169
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 3 residues within 4Å:- Chain B: N.50, N.53, E.57
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.50, B:N.53, B:E.57
NAG.12: 3 residues within 4Å:- Chain D: N.50, N.53, E.57
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:N.50, D:N.53, D:E.57
NAG.18: 3 residues within 4Å:- Chain F: N.50, N.53, E.57
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:N.50, F:N.53, F:E.57
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, H. et al., An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism. PLoS Pathog. (2016)
- Release Date
- 2016-03-23
- Peptides
- Hemagglutinin-esterase: ACE
Hemagglutinin-esterase: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CC
CE
CB
DD
DF
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x Z3Q- GAL- 5N6: 9-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid-(2-3)-beta-D-galactopyranose-(1-3)-2-azidoethyl 2-acetamido-2-deoxy-beta-D-glucopyranoside
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, H. et al., An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism. PLoS Pathog. (2016)
- Release Date
- 2016-03-23
- Peptides
- Hemagglutinin-esterase: ACE
Hemagglutinin-esterase: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CC
CE
CB
DD
DF
D